The Valley Desk

NCT01184885 · Interventional trial

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Overall registry status Completed

Early Phase 1

Conditions Acute Lymphoblastic Leukemia, Adult T-cell Leukemia/Lymphoma, Burkitt Lymphoma, Lymphoblastic Lymphoma, Lymphoid Malignancies (New or Relapsed), Mantle Cell Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov